Segmental wall motion abnormality analyzed by equilibrium radionuclide angiography and improvement in ventricular function by cardiac resynchronization therapy.
BACKGROUND
The purpose of this study was to determine the impact of the left ventricular (LV) segmental wall motion abnormalities detected by equilibrium radionuclide angiography (ERNA) on the improvement in LV and right ventricular (RV) function during biventricular (BIV) stimulation.


RESULTS
We studied 28 patients in NYHA functional classes III or IV and QRS duration > 150 ms on resting electrocardiogram. ERNA was performed before and during BIV stimulation at a 6-month follow-up. A significant shortening of QRS duration was observed during BIV stimulation (165 +/- 5 ms before vs 133 +/- 6 ms during, P < 0.01). Wall motion abnormalities (WMA) were observed in 16 patients (10 with nonischemic cardiomyopathies). In this group, LV and RV ejection fractions (EF) did not increase during BIV stimulation (LVEF = 22 +/- 2% vs 20 +/- 1.6%, ns; RVEF = 34 +/- 3% vs 37 +/- 3.8%, ns). Significant increases in RVEF (23 +/- 3.2% --> 38 +/- 2.9%, P = 0.001) and LVEF (20 +/- 2.5% --> 30 +/- 3%, P = 0.01) were observed in the group of patients without segmental WMA and with global hypokinesia (GH). In this group, a significant decrease in the dispersion in the phase of RV contraction was observed (SD = 39 +/- 5 vs 26 +/- 2 ms; P < 0.01). WMA predicted an increase in LVEF, in contrast to a baseline 6-minute-walk test, maximal oxygen consumption and LVEF, or amount of QRS shortening.


CONCLUSIONS
BIV stimulation increased in LV and RV EF in patients with ventricular dyssynchrony in absence of segmental WMA. ERNA was reliable in the selection of candidates for CRT.
Eder
Veronique
V
Service Medecine Nucleaire CHU Trousseau, Tours, France.
Fauchier
Laurent
L
Courtehoux
Maxime
M
Bonnet
Pierre
P
Babuty
Dominique
D
D000368:Aged; D002304:Cardiac Pacing, Artificial; D004562:Electrocardiography; D005260:Female; D015637:Gated Blood-Pool Imaging; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging*; D018497:Ventricular Dysfunction, Right / Q000000981:diagnostic imaging*